Safe and Effective Opioid Prescribing for Chronic Pain
March 10, 2012
The Conference Center at Waltham Woods, Waltham, MA
Accreditation | Agenda | Faculty | Registration
***PLEASE NOTE: THIS CONFERENCE IS IN WALTHAM, MA***
Target Audience
Physicians, nurse practitioners, physician assistants, pharmacists
Educational Objectives
At the conclusion of this activity, participants will be able to:
- Discuss the breadth and quality of evidence for the use of opioids for chronic pain, including current gaps in knowledge
- Describe appropriate assessment, monitoring and documentation strategies to meet best practice standards and medico-legal requirements to support opioid prescribing
- Apply a practical framework for decision-making on the initiation, maintenance, and discontinuation of opioid analgesics for the treatment of chronic pain
Educational Needs Addressed
The Board of Registration in Medicine and the DEA have identified excessive use of opiates in the treatment of patients as a major problem in the delivery of healthcare, both here and nationally. In 2009, the Board of Registration in Medicine found that one-third of the physicians who were disciplined were involved in opioid prescribing violations. Also in 2009, 10% of the physicians who were referred to the physician health services program – the program set up to help Massachusetts physicians with health concerns – had a drug-related problem.
Additionally, chronic pain management has increasingly fallen to clinicians, rather than pain specialists. These clinicians need education in how to work with their patients who are living with chronic pain: how to define chronic pain, how to manage its treatment, the tools available to assess pain, and the risk involved in prescribing opioids, and how to discontinue treatment, if necessary.
Location
LIVE MEETING
The Conference Center at Waltham Woods
860 Winter Street, Waltham, MA
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Boston University School of Medicine and the Massachusetts Board of Registration in Medicine. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this educational activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity was planned in collaboration with the Massachusetts Department of Public Health, the Massachusetts Hospital Association, and the Massachusetts Medical Society.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 4 hours of risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 5 hours of opioid education.
Support
This program is supported by an unrestricted educational grant from Purdue Pharma and Pfizer.
